Bush stem cell line ok for approval

For the first time since the linkurl:National Institutes of Health;http://www.nih.gov/ released its new guidelines for the derivation of human embryonic stem cell (hESC) lines last summer, a line approved under the Bush administration has been recommended for inclusion into the growing federal registry of lines eligible for federal funding. Human embryonic stem cellsImage: Wikimedia commons, Nissim BenvenistySubmitted by the WiCell Research Institute in Madison, Wisconsin, the WA01 (commonly

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
For the first time since the linkurl:National Institutes of Health;http://www.nih.gov/ released its new guidelines for the derivation of human embryonic stem cell (hESC) lines last summer, a line approved under the Bush administration has been recommended for inclusion into the growing federal registry of lines eligible for federal funding.
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
Submitted by the WiCell Research Institute in Madison, Wisconsin, the WA01 (commonly known as H1) stem cell line "is one of the most utilized lines in the world," NIH director Francis Collins said at a press conference this morning (January 22). It is linkurl:one of two lines;http://www.the-scientist.com/blog/display/55885/ that that accounted for more than 75% of hESC requests received by the National Stem Cell Bank in the last 10 years and was used in 60.9% of the published literature on hESCs, according to a linkurl:survey published;http://www.nature.com/nbt/journal/v27/n8/full/nbt0809-696.html in the August issue of Nature Biotechnology. On the basis of a working group's findings, the NIH advisory committee to the director (ACD) advised Collins that the line was approved ethically according to the current stem cell guidelines. Collins said he will take the ACD's recommendation "under consideration and make a decision very soon." Collins also responded to a linkurl:question;http://www.the-scientist.com/blog/display/56204/ that previously arose regarding restrictions that may be stated in the informed consent forms. Funding of linkurl:27 lines;http://www.the-scientist.com/blog/display/56219/ from Harvard University, for example, was approved with the limitation that research involving these lines be restricted to the use specifically stated on the consent forms: diabetes-related pancreatic research. Today Collins announced that this practice would become the "general policy" of the NIH, which "should honor the exact wording [regarding the use of the donated embryos] as written in the informed consent forms." A total of 42 lines are linkurl:currently available;http://grants.nih.gov/stem_cells/registry/current.htm on the registry, including two added last Tuesday.
**__Related stories:__***linkurl:27 more hESC lines approved;http://www.the-scientist.com/blog/display/56219/
[15th December 2009]*linkurl:27 more hESC lines head for OK;http://www.the-scientist.com/blog/display/56204/
[4th December 2009]*linkurl: NIH OKs 13 stem cell lines;http://www.the-scientist.com/blog/display/56196/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA